Immunotherapy for Acute Myelogenous Leukaemia

One hundred and seven untreated patients with acute myelogenous leukaemia (AML) were admitted to St Bartholomew's Hospital between 10 October 1970 and 31 January 1973. Before receiving drugs to induce remission they were allocated alternatively into 2 groups to decide their remission treatment—...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 1973-11, Vol.28 (5), p.365-376
Hauptverfasser:	Powles, R L, Crowther, D, Bateman, C J T, Beard, M E J, McElwain, T J, Russell, J, Lister, T A, Whitehouse, J M A, Wrigley, P F M, Pike, M, Alexander, P, Fairley, G. Hamilton
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult BCG Vaccine Biomedical and Life Sciences Biomedicine Cancer Research Cytarabine - therapeutic use Daunorubicin - therapeutic use Drug Resistance Epidemiology Female Histocompatibility Testing Humans Immunity Immunotherapy Injections, Intradermal Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - immunology Leukemia, Myeloid, Acute - mortality Leukemia, Myeloid, Acute - therapy Lymphocyte Activation Lymphocytes - drug effects Male Middle Aged Molecular Medicine Oncology original-article Plicamycin - pharmacology Remission, Spontaneous Statistics as Topic Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!